Aceto Investors Can't Resurrect Securities Suit
Investors in pharmaceutical company Aceto Corp. can't get their securities fraud suit against the company revived on the basis of a recent Second Circuit opinion, a New York federal judge has...To view the full article, register now.
Already a subscriber? Click here to view full article